Ayşen Kılıçaslan

Ayşen Kılıçaslan

Auto-generated profile, based on publicly available information

Ayşen Kılıçaslan

Antalya Egitim ve Arastirma Hastanesi

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2025 in Biotechnic & Histochemistry
Verified
Journal Article
Closed access
TYTuran Can Yıldız
Turan Can Yıldız
KEKemal Eyvaz
Kemal Eyvaz
HEHamit Yaşar Ellidag
Hamit Yaşar Ellidag
AKAyşen Kılıçarslan
Ayşen Kılıçarslan
ÖÇÖmer Çelik
Ömer Çelik
AAArif Aslaner
Arif Aslaner
Liver ischemia and ischemia/reperfusion (I/R) injury are common in hepatic resection, trauma surgery, and transplantation and contribute to postoperative morbidity and mortality. This study aimed to investigate the relationship between early histopathological changes due to liver I/R injury and serum levels of perilipin-2 (Plin2) and other oxidative stress biomarkers. Fifty female Wistar albino rats were divided into five groups: Group 1 (control), Group 2 (ischemia for 30 minutes), and Groups 3-5 (ischemia followed by 1, 2, or 3 hours of reperfusion). Intracardiac and arterial blood samples were collected for biochemical analysis, while liver tissue samples were used for histopathological examination. Serum levels of Plin2, ischemia-modified albumin (IMA), total antioxidant status (TAS), and total oxidant status (TOS) were measured. Plin2 levels were significantly lower in the ischemia group compared to others (p < 0.01). The control group had significantly lower IMA, TOS, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels (p < 0.01) and lower TAS levels (p < 0.05). Rats with Grade 1 liver injury showed significantly lower Plin2 (p < 0.01) and higher IMA levels (p < 0.05). Reduced serum Plin2 following ischemia suggests its potential as a biomarker for acute liver injury. Further studies are needed to clarify its role across different reperfusion durations.

21 April 2021 in Journal of Turkish Spinal Surgery
Verified
Journal Article
Closed access
ÖKömer faruk Kılıçaslan
ömer faruk Kılıçaslan
AKAyşen Kılıçaslan
Ayşen Kılıçaslan
VNVugar Nabi
Vugar Nabi
SASerdar Akalın
Serdar Akalın

17 March 2026 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Closed access
ŞYŞenay Yıldırım
Şenay Yıldırım
BKBarış Rafet Karakaş
Barış Rafet Karakaş
AKAyşen Kılıçaslan
Ayşen Kılıçaslan
AÖArif Hakan Hakan Önder
Arif Hakan Hakan Önder
ÖGÖzlem Vardar Gök
Özlem Vardar Gök
Aim: Occult breast cancer (OBC) is a rare clinical entity characterized by axillary lymph node metastasis without a detectable primary tumor in the breast. This study aimed to evaluate the clinicopathological features and the impact of different treatment modalities on survival in patients diagnosed with OBC.Methods: A total of 14 patients diagnosed with OBC between 2016 and 2024 were retrospectively analyzed. Diagnosis was confirmed clinically and through multimodal imaging, including ultrasonography, mammography, magnetic resonance imaging (MRI), and positron emission tomography/computed tomography (PET-CT). Demographic data, immunohistochemical profiles, surgical interventions, systemic therapies, and survival rates were evaluated.Results: The cohort was predominantly female (92.9%), with a mean age of 54.6 years. The most common presenting symptom was a palpable axillary mass (71.4%). Molecular subtypes were identified as Luminal A (50%), Luminal B (35.7%), and Triple-Negative (14.3%). The 5-year survival rate was 100% in patients who underwent either modified radical mastectomy (MRM) or breast-conserving surgery (BCS) combined with axillary lymph node dissection (ALND). In contrast, the survival rate was 50% for those who underwent ALND alone and 0% for those who received no surgical intervention (p=0.003). While radiotherapy was associated with a higher 5-year survival rate compared to no radiotherapy (90.9% vs. 50%), this difference was not statistically significant (p=0.083). No significant associations were found between survival and age, smoking status, neoadjuvant chemotherapy, or endocrine therapy (p>0.05).Conclusions: Multimodal treatment is essential for OBC. Breast-directed surgery combined with axillary dissection significantly improves survival compared to either axillary dissection alone or no surgical intervention.Keywords: Axillary lymph node metastases; occult breast carcinoma; radiotherapy; surgery; survival